HSBC Holdings
PVLA

HSBC Holdings’s Palvella Therapeutics PVLA Stock Holding History

HSBC Holdings’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-202
Closed -$2.72K – 2879
2023
Q2 		$2.72K Hold
202
– – ﹤0.01% 2541
2023
Q1 		$15.8K Hold
202
– – ﹤0.01% 2617
2022
Q4 		$15.2K Sell
202
-44
-18% -$3.54K ﹤0.01% 3024
2022
Q3 		$22K Sell
246
-6
-2% -$774 ﹤0.01% 2867
2022
Q2 		$39K Sell
252
-5
-2% -$912 ﹤0.01% 3161
2022
Q1 		$63K Buy
257
+92
+56% +$24.2K ﹤0.01% 3182
2021
Q4 		$50K Hold
165
– – ﹤0.01% 3201
2021
Q3 		$70K Buy
+165
New +$57.5K ﹤0.01% 2915

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HSBC Holdings's PVLA Position: Q3 2023 in Review

HSBC Holdings sold out of Palvella Therapeutics (PVLA) in Q3 2023, closing a stake of 202 shares — an estimated $2.72K sold.

HSBC Holdings first reported a position in PVLA in Q3 2021 and held it in 8 quarters. The position peaked at $70K in Q3 2021. 43 funds tracked by Wall St. Rank hold PVLA as of Q3 2023.

  • HSBC Holdings reported no remaining Palvella Therapeutics position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 202 Palvella Therapeutics shares in Q3 2023, an estimated $2.72K.
  • HSBC Holdings first reported a position in Palvella Therapeutics in Q3 2021 and held it in 8 quarters.
  • HSBC Holdings's Palvella Therapeutics position peaked at $70K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.